Relationship between Changes in Ejection Fraction, BNP and Norepinephrine over Time and the Effect of Valsartan in Val-HeFT

Inder S. Anand; Roberto Latini; Maylene Wong; Serge Masson; Aldo Maggioni; Allen Hester; Nora Aknay; Jay N. Cohn

doi:10.1016/s1071-9164(03)00450-0

Back

Relationship between Changes in Ejection Fraction, BNP and Norepinephrine over Time and the Effect of Valsartan in Val-HeFT

Article 2003 en

Discussion(0)

No comments yet. Be the first to comment.

Related publications

Article2003

Changes in Brain Natriuretic Peptide and Norepinephrine Over Time and Mortality and Morbidity in the Valsartan Heart Failure Trial (Val-HeFT)

Inder S. Anand, Lloyd D. Fisher, YannTong Chiang, Roberto Latini, Serge Masson, Aldo Maggioni, Robert Glazer, Gianni Tognoni, Jay N. Cohn

Article2003

Changes in plasma brain natriuretic peptide and norepinephrine over time and subsequent mortality and morbidity in heart failure: Results from Val-HeFT

Inder S. Anand, Lloyd D. Fisher, Yann-Tom Chiang, Roberto Latini, Serge Masson, Aldo Maggioni, Robert Glazer, Gianni Tognoni, Jay N. Cohn

Article2022

Association between sacubitril/valsartan initiation and changes in left ventricular ejection fraction: Insights from ARIADNE registry

Lars H. Lund, Uwe Zeymer, Andrew L. Clark, Vivencio Barrios, Thibaud Damy, Jarosław Dróżdż, Cândida Fonseca, Stefanie Kalus, Philippe Ferber, C Koch, Aldo Maggioni

Article2004

Effect of Valsartan Added to Background ACE Inhibitor Therapy in Patients with Heart Failure: Results from Val-HeFT

Henry Krum, Peter E. Carson, Csaba Farsang, Aldo Maggioni, Robert Glazer, Nora Aknay, YannTong Chiang, Jay N. Cohn

Article2005

Valsartan Reduces the Incidence of Atrial Fibrillation in Patients With Heart Failure: Results From the Valsartan Heart Failure Trial (Val-HeFT)

Aldo Maggioni, Roberto Latini, Peter E. Carson